Iridium Complexes with Silylated Ligands for OLED Efficiency
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a continuing need for electroluminescent compounds with improved performance and stability in organic electronic devices, particularly for light-emitting diodes, as existing compounds face issues with luminescence efficiency and stability.
Innovation Solution
The development of electroluminescent Ir(III) complexes with silylated, germanylated, and stannylated ligands, which are hexacoordinate and neutral, and their use in electronic devices with specific ligand structures and synthesis processes to enhance luminescence efficiency and stability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional electroluminescent compounds are used, then device structure is simple, but luminescence efficiency and stability are insufficient
Solution Approach 1:
The patent employs composite material design by combining iridium metal center with specifically engineered organic ligands containing silylated, germanylated, or stannylated groups. This composite approach creates novel electroluminescent complexes that achieve superior luminescence efficiency and stability compared to simple organic compounds, while the systematic ligand design keeps the synthesis pathway manageable.
Solution Approach 2:
The patent systematically varies key parameters including the type of group 14 element (Si, Ge, Sn), the length of alkyl chains, and the specific positioning of substituents on the ligand framework. These parameter changes allow optimization of luminescence properties and stability without fundamentally changing the overall molecular architecture, thus improving performance while controlling complexity.
2Productivity
If existing electroluminescent compounds are used, then manufacturing process is straightforward, but self-quenching occurs in solid-state devices
Solution Approach 1:
The patent introduces local quality modifications by incorporating bulky silylated, germanylated, or stannylated groups at specific positions on the ligand framework. These localized structural features create steric protection around the iridium center, preventing close intermolecular interactions that cause self-quenching, while maintaining the overall molecular structure suitable for solid-state device fabrication.
3Reliability
If simple organic molecules are used, then synthesis is easy, but luminescence efficiency is limited
Solution Approach 1:
The patent applies segmentation by dividing the electroluminescent complex into distinct functional modules: the iridium center, the cyclometalating ligand, and the ancillary ligand. Each module can be independently optimized and synthesized, then assembled through well-established coordination chemistry protocols. This modular approach achieves high luminescence efficiency while keeping the overall manufacturing process systematic and controllable.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The Ir(III) complexes exhibit enhanced luminescence efficiency, stability, and reduced non-radiative decay rates, allowing for improved performance and reduced self-quenching in solid-state devices, leading to more efficient electroluminescent properties.
Implementation Method 1
The organic active layer emits light through the light-transmitting electrical contact layer upon application of electricity across the electrical contact layers
Implementation Method 2
The Ir(III) complexes exhibit enhanced luminescence efficiency, stability, and reduced non-radiative decay rates
Data Source
AI summary
The present invention is directed to electroluminescent complexes of iridium(III) with silylated, germanylated and stannylated ligands. The invention is further directed to electronic devices in which the active layer includes an electroluminescent Ir(III) complex with silylated, germanylated and stannylated ligands.